Research Progress of HGF/c-MET Inhibitor in the Treatment 
of Non-small Cell Lung Cancer

Research Progress of HGF/c-MET Inhibitor in the Treatment 
of Non-small Cell Lung Cancer

Molecular targeted therapy has become more and more important in the treatment of non-small cell lung cancer (NSCLC). HGF/c-MET plays the pivotal role in the growth, development and tolerance to epidermal growth factor receptor tyrosine kinase inhibitor of NSCLC. Moreover it has become another heat...

Full description

Bibliographic Details
Main Authors: Tao JIANG, Caicun ZHOU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-04-01
Series:Chinese Journal of Lung Cancer
Subjects:
HGF
c-MET
Lung neoplasms
Inhibitor
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2015.04.09

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2015.04.09

Similar Items